No Data
No Data
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?
Barclays Remains a Hold on Roche Holding AG (RHHVF)
Why This Gene-Therapy Company's Stock Is Rising 228% -- Barrons.com
Roche to Acquire CAR-T Cell Therapy Focused Poseida for $1.5B
Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details
Roche Holding AG (RHHVF) Receives a Sell From Goldman Sachs
JCpennyStonks : Your indicator is broken
Sor Shi Dll OP JCpennyStonks : let's see it support previous low at 35!